Trials / Completed
CompletedNCT03081975
Comparison of ADR Using NBI Versus HD White Light Colonoscopy in Screening and Surveillance Colonoscopies
Comparison of Adenoma Detection Rate Using Narrow Band Imaging Versus HD White Light Colonoscopy in Screening and Surveillance Colonoscopies
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- Jena University Hospital · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to compare ADR using HD-NBI or HD-WLE during screening and surveillance colonoscopies.
Detailed description
Background: Despite recent advances in endoscopic technology adenoma miss rate still is up to 20% and contributes to the occurrence of interval cancers. Therefore, improved imaging modalities have been introduced to increase adenoma detection rate (ADR) during screening and surveillance colonoscopies. Recently, narrow band imaging (NBI; Exera II series, Olympus Corporation) was not significantly better than high definition white light colonoscopy (WLC) for the detection of patients with colorectal polyps, or colorectal adenomas1. However, Olympus' current Exera III series is characterized by better illumination of the bowel lumen and may be associated with a higher ADR than high definition WLC. Methods: Investigators performed a prospective evaluation in patients referred to the Department of Interdisciplinary Endoscopy at Jena University Hospital for screening or surveillance colonoscopy between January and November 2015 in daily clinical practice. Colonoscopy was performed by use of HD-WLC or HD-NBI upon withdrawal of the colonoscope (Exera III series, Olympus Corporation).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HD white light or NBI | Use of NBI or HD white light |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2017-03-17
- Last updated
- 2018-03-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03081975. Inclusion in this directory is not an endorsement.